Vaccination News Home Page

http://bmj.com/cgi/content/full/324/7349/1294/b

BMJ Intended for US health professionals - Click here for further information
 

Home Help Search/Archive Feedback Table of Contents

PDF of this article
Email this article to a friend
Respond to this article
PubMed citation
Related articles in PubMed
Download to Citation Manager
Search Medline for articles by:
Dorozynski, A.
Alert me when:
New articles cite this article
 
Collections under which this article appears:
Other Endocrinology
Medicine and the law (incl forensic medicine)
Children

BMJ 2002;324:1294 ( 1 June )

News

Parents sue over contaminated human growth hormone

Alexander Dorozynski, Paris

The family of a woman who received growth hormone in 1985 and who went on to develop Creutzfeld-Jakob disease in 1999 and died in June last year is suing the Pasteur Institute and France-Hypophyse, an association that was responsible for the collection of pituitaries, for compensation.

The family refused the government's compensation offer of 300000 (£190 000; $276 000) and decided to sue to break the deadlock of a judicial investigation begun 10 years ago and still not completed.

According to the National Institute of Sanitary Surveillance, 81 people have died in France of Creutzfeld-Jakob disease after injections of growth hormone prepared by the Pasteur Institute from pituitary glands taken from cadavers in France and eastern Europe.

A centralised system involving the extraction of growth hormone by the Pasteur Institute was set up in 1973.

In 1985 it was reported that patients treated with growth hormone were at risk of developing Creutzfeld-Jakob disease. The use of growth hormone extracted from cadavers was then discontinued in the United States and several other countries. In the same year growth hormone was successfully produced by recombinant DNA techniques.

However, France continued to use extracted hormone, after adding another step of viral inactivation to the process, until 1988, when it switched to recombinant growth hormone.

Pascale Fachin, the patient whose parents initiated the lawsuit, received extracted growth hormone in 1985, when she was 14, because she had not reached her expected height.

She led a normal life until 1999, when Creutzfeld-Jakob disease was diagnosed. She died last year, at the age of 30.

 


© BMJ 2002
 

PDF of this article
Email this article to a friend
Respond to this article
PubMed citation
Related articles in PubMed
Download to Citation Manager
Search Medline for articles by:
Dorozynski, A.
Alert me when:
New articles cite this article
 
Collections under which this article appears:
Other Endocrinology
Medicine and the law (incl forensic medicine)
Children


 

 


Home Help Search/Archive Feedback Table of Contents

BMJ Intended for Health Professionals - click here!!
 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.